NCT04851873: Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA)
- State
- Completed
- Phase
- Phase 3
- People
- 24 taking part
- Started
- 8 Sep 2021
- Primary completion
- 13 Jun 2023
- Arms
- OAV101
- Results
- Posted on the registry
- 21 Apr 2021: Trial registered
- 8 Sep 2021: Trial started
- 13 Jun 2023: Trial completed
- 5 Jan 2024: Trial results posted